Le Lézard
Classified in: Health
Subjects: AWD, NPT, TDS

Lymphoma Research Foundation Honors Southern Glazer's Wine & Spirits with 2019 Hope Award


NEW YORK, June 13, 2019 /PRNewswire-PRWeb/ -- The Lymphoma Research Foundation (LRF) ? the nation's largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services ? presented the 2019 Hope Award to Southern Glazer's Wine & Spirits (SGWS), the world's pre-eminent distributor of beverage alcohol. The company was honored during the third installment of Swirl: Chicago on May 30 at the Casino in Chicago.

Given in recognition of corporations, businesses and individuals who have worked diligently toward the Foundation's mission of eradicating lymphoma and serving those impacted by this blood cancer, the 2019 Hope Award was presented to SGWS in appreciation of the support of LRF's Swirl: A Wine Tasting Event series, where SGWS is a Founding Sponsor. Since 2013, the Foundation has been able to expand its series from its inaugural market in Miami to five additional markets including Chicago, Dallas, Minneapolis, New York City, and Orange County, Calif. In addition, the Foundation marked a major milestone for the series, raising more than $1 million since the series' inception.

The Hope Award was presented by LRF's Chair of the Board of Directors, Michael Werner during a special award ceremony at Swirl: Chicago. LRF Board member, steadfast supporter of the Foundation's Swirl series and Executive Vice President of Commercial Operations at Southern Glazer's Wine & Spirits Kevin Fennessey accepted the award on behalf of SGWS.

"As the Founding Sponsor of the Swirl series, Southern Glazer's is incredibly inspired by the series' tremendous success and the impact our partnership has on the lymphoma community," said Kevin Fennessey, Executive Vice President of Commercial Operations at Southern Glazer's Wine & Spirits. "We look forward to our continued partnership and expanding to more communities to further our support of LRF and all those impacted by a lymphoma diagnosis."

"We are grateful for Southern Glazer's Wine & Spirits support of the Swirl: A Wine Tasting Event series," said Meghan Gutierrez, Chief Executive Officer at the Lymphoma Research Foundation. "Due to their extraordinary generosity and commitment to LRF's mission, we were able to not only raise more than $1 million but also bring together philanthropic communities around the country to make an impact on lymphoma research and the lives of people affected by this blood cancer. We are honored to show our gratitude to SGWS by presenting them with the 2019 Hope Award."

For more information about Swirl: A Wine Tasting Event, visit lymphoma.org/swirl.

About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation's largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $62 million in lymphoma-specific research. For additional information on LRF's research, education and services, visit lymphoma.org.

About Southern Glazer's Wine & Spirits
Southern Glazer's Wine & Spirits is the world's pre-eminent distributor of beverage alcohol, and proud to be a multi-generational, family-owned company. The Company has operations in 44 U.S. states and the District of Columbia, Canada, and the Caribbean, and employs more than 20,000 team members. Southern Glazer's urges all retail customers and adult consumers to market, sell, serve, and enjoy its products responsibly. For more information visit http://www.southernglazers.com. Follow us on Twitter and Instagram @sgwinespirits, and on Facebook at http://www.facebook.com/SouthernGlazers.

 

SOURCE Lymphoma Research Foundation


These press releases may also interest you

7 déc 2019
Unlearn.AI, developer of the first machine-learning (ML) platform that creates Digital Twins to populate Intelligent Control Arms in clinical studies, today presented results generated from the company's latest Alzheimer's disease model at the...

7 déc 2019
The 12-Step fellowship, Nicotine Anonymous (NicA), has grown in 37 years to have over 700 weekly ongoing face-to-face mutual support groups in 32 countries. At meetings members share their experience with a process of recovery from nicotine...

7 déc 2019
MaaT Pharma announced today that leading hemato-oncological experts presented clinical data on the compassionate use of MaaT Pharma's lead full-ecosystem microbiome restoration biotherapeutic, MaaT013. The data included eight patients that developed...

7 déc 2019
Magenta Therapeutics , a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, today announced that new results from its MGTA-145 stem cell mobilization program were presented at...

7 déc 2019
The Bristol-Myers Squibb-Pfizer Alliance today announced results from retrospective real-world data analyses reporting outcomes on the safety and effectiveness of Eliquis® (apixaban) compared to low molecular weight heparin (LMWH) or warfarin for the...

7 déc 2019
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Baxter International Inc. between February 21, 2019 and October 23, 2019, inclusive (the "Class Period") of the important January 24, 2020 lead plaintiff...



News published on 13 june 2019 at 12:00 and distributed by: